# A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D

> **NCT06247046** · PHASE3 · RECRUITING · sponsor: **Guangzhou Zhiyi Biotechnology Co., Ltd.** · enrollment: 1298 (estimated)

## Conditions studied

- Irritable Bowel Syndrome With Diarrhea

## Interventions

- **DRUG:** Live SK08 powder
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06247046
- **Lead sponsor:** Guangzhou Zhiyi Biotechnology Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-16
- **Primary completion:** 2026-04
- **Final completion:** 2027-01
- **Target enrollment:** 1298 (ESTIMATED)
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06247046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06247046, "A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06247046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*